Please assess the completion status of the following clinical trial:

Trial Title: Stellate Ganglion Blockade to Reduce Cardiac Anxiety and PTSD Symptoms in Cardiac Arrest Survivors

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria~1. Age 18 years or older~2. Fluent in English or Spanish~3. A diagnosis of cardiac arrest (CA)~4. Admitted to the New York-Presbyterian Hospital~5. Elevated symptoms of psychological distress a. PCL-5 \> 32 with a minimum of 2 weeks after cardiac arrest~Exclusion criteria~1. A prior SGB treatment~2. Severe brain injury defined as Cerebral Performance Category Score ≥3, and/or significant aphasia, dysarthria, or cognitive impairment precluding ability to complete study questionnaires as determined by interviewer~3. Terminal non-cardiovascular illness (life expectancy \<1 year)~4. Severe mental illness requiring urgent psychiatric hospitalization~5. Alcohol or substance abuse that would impede ability to complete study~6. Unavailable for telephone and in-person follow-up~7. Allergy to amide local anesthetics (e.g., ropivacaine, bupivacaine)~8. Pre-existing Horner's syndrome~9. Pregnancy~10. Current anticoagulant use~11. History of a bleeding disorder~12. Infection or mass at injection site

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Stellate Ganglion Block + Psychoeducation (Type: EXPERIMENTAL): For the active SGB arm, 7 to 8 mL of ropivacaine, 0.5%, will be injected around and into the site of the ganglion once before the hospital discharge. They will also receive a 30 minutes session of psychoeducation by a health professional with experience working with CA patients.
- Normal saline injection + Psychoeducation (Type: PLACEBO_COMPARATOR): For the sham procedure, 1 to 2 mL of preservative-free normal saline will be injected into deep musculature in the neck. They will also receive a 30 minutes session of psychoeducation by a health professional with experience working with CA patients.

Based on this trial design, predict the completion outcome and termination type (if applicable).